In this review:
Will GS-7977 end response- guided therapy in HCV GT1?
Using PEG-based therapy in advanced liver disease
Telaprevir and boceprevir in the post-transplant setting
IFN-free GS-7977/RBV: consistent antiviral suppression
IFN-free regimens p
Please login below to download this issue (PDF)